Seelos Therapeutics to Participate in the Benchmark Healthcare Virtual Conference
May 18 2020 - 8:01AM
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage
biopharmaceutical company focused on the development of therapies
for central nervous system disorders and rare diseases, today
announced that it will participate in the Benchmark Company
Healthcare House Call Virtual Video 1x1 Investor Conference, June
15-16, 2020.
Raj Mehra, Ph.D., Chairman and CEO, will host
meetings via conference calls.
For additional information about the Benchmark
Company Healthcare House Call Virtual Video 1x1 Investor
Conference:
https://benchmark-healthcare-house-call-virtual.events.issuerdirect.com/
About Seelos Therapeutics:
Seelos Therapeutics, Inc. is a clinical-stage
biopharmaceutical company focused on the development and
advancement of novel therapeutics to address unmet medical needs
for the benefit of patients with central nervous system (CNS)
disorders and other rare diseases. The Company's robust portfolio
includes several late-stage clinical assets targeting indications
including Acute Suicidal Ideation and Behavior (ASIB) in Major
Depressive Disorder (MDD) or Post-Traumatic Stress Disorder (PTSD),
Sanfilippo syndrome, Parkinson’s Disease, other psychiatric and
movement disorders plus orphan diseases.
For more information, please visit our website:
http://seelostherapeutics.com, the content of which is not
incorporated herein by reference.
Contact Information:
Anthony Marciano Head of Corporate Communications
Seelos Therapeutics, Inc. (Nasdaq: SEEL) 300 Park Ave., 12th Fl New
York, NY 10022 (646) 293-2136
anthony.marciano@seelostx.comhttps://seelostherapeutics.com/https://twitter.com/seelostxhttps://www.linkedin.com/company/seelos
Seelos Therapeutics (NASDAQ:SEEL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Seelos Therapeutics (NASDAQ:SEEL)
Historical Stock Chart
From Apr 2023 to Apr 2024